Loading...

Purified anti-mouse/human CD45R/B220 Antibody

Pricing & Availability
Clone
RA3-6B2 (See other available formats)
Regulatory Status
RUO
Other Names
B220
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
1_RA3-6B2_Pure_112911
C57BL/6 mouse slenocytes were stained with purified B220 (clone RA3-6B2) (filled histogram) or rat IgG2a, κ (open histogram), followed by anti-rat IgG FITC.
  • 1_RA3-6B2_Pure_112911
    C57BL/6 mouse slenocytes were stained with purified B220 (clone RA3-6B2) (filled histogram) or rat IgG2a, κ (open histogram), followed by anti-rat IgG FITC.
  • 2_RA3-6B2_PURE_CD45R_IHC-F_091018
    C57BL/6 mouse frozen spleen section was fixed with 4% paraformaldehyde (PFA) for ten minutes at room temperature and blocked with 5% FBS for 30 minutes at room temperature. Then, the section was stained with 10 µg/mL of purified anti-mouse/human CD45R/B220 (clone RA3-6B2) and anti-mouse CD3ε (clone 500A2) Alexa Fluor® 594 (red) overnight at 4°C, followed by 2.5 µg/mL of anti-rat IgG (clone Poly4054) Alexa Fluor® 488 (green) for two hours at room temperature. Nuclei were counterstained with DAPI (blue). The image was captured by 10X objective.
  • RA3-6B2_PURE_CD45R_IHC-F_102418
    Fresh, frozen mouse spleen was stained with purified CD45R/B220 clone Ra3-6B2 conjugated and detected with a FITC CODEX™ oligonucleotide duplex (red). Samples were counterstained with TCT A647 (green). Data generated at Akoya Biosciences, Inc. using the CODEX™ technology.
Cat # Size Price Quantity Check Availability Save
103201 50 µg 30 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103202 500 µg 83 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45R, also known as B220, is an isoform of CD45. It is a member of the protein tyrosine phosphatase (PTP) family with a molecular weight of approximately 180-240 kD. CD45R is expressed on B cells (at all developmental stages from pro-B cells through mature B cells), activated B cells, and subsets of T and NK cells. CD45R (B220) is also expressed on a subset of abnormal T cells involved in the pathogenesis of systemic autoimmunity in MRL-Faslpr and MRL-Fasgld mice. It plays a critical role in TCR and BCR signaling. The primary ligands for CD45 are galectin-1, CD2, CD3, and CD4. CD45R is commonly used as a pan-B cell marker; however, CD19 may be more appropriate for B cell specificity.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse,Human
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Abelson murine leukemia virus-induced pre-B tumor cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
CyTOF®, IHC-F - Verified
IHC-P, IP, Activ - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. For immunohistochemistry on frozen tissue sections, a concentration range of 5.0 - 10 µg/ml is suggested. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro and in vivo modulation of B cell responses2-4, immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6, and spatial biology (IBEX)14,15.

Application References

(PubMed link indicates BioLegend citation)
  1. Coffman RL. 1982. Immunol. Rev. 69:5. (IP)
  2. George A, et al. 1994. J. Immunol. 152:1014. (Activ)
  3. Asensi V, et al. 1989. Immunology 68:204. (Activ)
  4. Domiati-Saad R, et al. 1993. J. Immunol. 151:5936. (Activ)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Monteith CE, et al. 1996. Can. J. Vet. Res. 60:193. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Chang C L-T, et al. 2007. J. Immunol. 178:6984.
  9. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  10. Lang GL, et al. 2008. Blood 111:2158. PubMed
  11. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  12. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  13. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  14. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  15. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Nagashima K, et al. 2017. Biochem Biophys Res Commun. . 10.1016/j.bbrc.2017.09.004. PubMed
  2. Ma W, et al. 2017. Sci Rep. . 10.1038/s41598-017-15661-6. PubMed
  3. Gröschel C, et al. 2017. Sci Rep.. 10.1038/s41598-017-16147-1. PubMed
  4. Quaranta V, et al. 2018. Cancer Res. 2018:5379085. PubMed
  5. Grohmann M et al. 2018. Cell. 175(5):1289-1306 . PubMed
  6. De Schepper S et al. 2018. Cell. 175(2):400-415 . PubMed
  7. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  8. Adamson SE, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1020. PubMed
  9. Baluk P, et al. 2018. Methods Mol Biol. 1846:161. PubMed
  10. Dubey LK, et al. 2019. Cell Rep. 27:2442. PubMed
  11. Chung WY, et al. 2018. ALTEX. 36:29. PubMed
  12. Yin S et al. 2019. Cancer cell. 35(2):283-296 . PubMed
  13. Simmons S et al. 2019. Elife. 8 pii: e41239. PubMed
  14. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  15. Telford W, et al. 2017. Cytometry A. 91:314. PubMed
  16. Wang HC, et al. 2017. J Immunol. 198:3149. PubMed
  17. Dallari S, et al. 2017. Nat Commun. 8:14830. PubMed
  18. Schneppenheim J, et al. 2017. J Immunol. 199:172. PubMed
  19. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  20. Akiel M, et al. 2017. Cancer Res. 77:4014. PubMed
  21. Chiu H, et al. 2017. Front Immunol. 0.852083333. PubMed
  22. Kawabe T, et al. 2017. Sci Immunol. 2:eaam9315. PubMed
  23. Goel S, et al. 2017. Nature. 548:471. PubMed
  24. Wang W, et al. 2018. J Vasc Surg. 68:1538. PubMed
  25. Parigi SM, et al. 2018. Sci Rep. 0.440277778. PubMed
  26. Duncan CG, et al. 2018. G3 (Bethesda). 0.892361111. PubMed
  27. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  28. Manni M, et al. 2018. Nat Immunol. 1.074305556. PubMed
  29. Sun H, et al. 2018. J Cell Biol. 217:1453. PubMed
  30. Fonseca JA, et al. 2018. Vaccine. 36:2799. PubMed
  31. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  32. Wan X, et al. 2018. Nature. 560:107. PubMed
  33. Ito Y, et al. 2018. J Exp Med. 215:2617. PubMed
  34. Zhao L, et al. 2018. Nat Med. 24:1536. PubMed
  35. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  36. Piliponsky AM, et al. 2019. Nat Immunol. 0.922916667. PubMed
  37. Chen S, et al. 2018. Immunohorizons. 0.345138889. PubMed
  38. Rosenbaum M, et al. 2019. Nat Commun. 2.05. PubMed
  39. Stebegg M, et al. 2019. Nat Commun. 2.113194444. PubMed
  40. Yamashita M, et al. 2019. Cell Stem Cell. 25:357. PubMed
  41. Ng SR, et al. 2020. Proc Natl Acad Sci U S A. 117:513. PubMed
  42. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  43. Cole C, et al. 2018. Nucleic Acids Res. 46:e62. PubMed
  44. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  45. Niss Arfelt K, et al. 2017. Blood. 129:866. PubMed
  46. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  47. Englezou PC, et al. 2018. Mol Ther Nucleic Acids. 12:118. PubMed
  48. Mazor R, et al. 2018. Proc Natl Acad Sci U S A. 115:E733. PubMed
  49. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  50. King IL, et al. 2017. Mucosal Immunol. 10:1160. PubMed
  51. Yoon BH, et al. 2018. Mol Cells. 41:953. PubMed
  52. Umemoto T, et al. 2017. EMBO J. 36:2390. PubMed
  53. Luo W, et al. 2019. Nat Immunol. 20:736. PubMed
  54. Mainini F, et al. 2018. Nucleic Acid Ther. 28:225. PubMed
  55. Shin J, et al. 2018. Diabetes. 67:1068. PubMed
  56. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  57. Chen L, et al. 2019. Nat Commun. 3.553472222. PubMed
  58. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  59. Lang G, et al. 2008. Blood. 111:2158. PubMed
  60. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  61. Lebert-Ghali C, et al. 2016. Blood. 127: 87-90. PubMed
  62. Alrefai H, et al. 2016. Nat Commun. 7:11724. PubMed
  63. Fujimura N, et al. 2016. J Vasc Surg. 64: 46-54. PubMed
  64. Dungubat E, et al. 2020. Nutrients. 12:00. PubMed
  65. Feng X, et al. 2020. DNA Repair (Amst). 86:102754. PubMed
  66. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  67. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  68. Heib T, et al. 2021. Cell Reports. 35(6):109102. PubMed
  69. Schafflick D, et al. 2020. Nat Commun. 247:11. PubMed
  70. Conlon TM, et al. 2020. Nature. 588:151. PubMed
  71. Messal HA, et al. 2020. Nat Protoc. 16:239. PubMed
  72. Tran JQ, et al. 2020. Blood Adv. 4:5547. PubMed
  73. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  74. Vukman KV, et al. 2020. J Extracell Vesicles. 10:e12023. PubMed
  75. Sugita J, et al. 2021. Nat Commun. 12:1910. PubMed
  76. Chen HW, et al. 2021. Biomedicines. 9:. PubMed
  77. Ikezoe T, et al. 2021. Biomolecules. 11:. PubMed
  78. Kimishima Y, et al. 2021. Nat Commun. 12:6177. PubMed
  79. Baluk P, et al. 2020. Am J Pathol. 190:2355. PubMed
  80. Kobayashi A, et al. 2021. Front Immunol. 12:650856. PubMed
  81. Nguyen N, et al. 2022. iScience. 25:103679. PubMed
  82. Prabakaran T, et al. 2021. EBioMedicine. 66:103314. PubMed
  83. Yang M, et al. 2020. Oncoimmunology. 9:1708064. PubMed
  84. Lin Z, et al. 2021. Stem Cells. 39:240. PubMed
  85. Link CWM, et al. 2020. Front Immunol. 11:596772. PubMed
  86. Bajaña S, et al. 2021. Front Immunol. 11:577718. PubMed
  87. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  88. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  89. Cardoso F, et al. 2021. Nature. 597:410. PubMed
  90. Tian K, et al. 2021. J Immunol Res. 2021:6297332. PubMed
  91. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  92. Ravell JC, et al. 2020. J Clin Invest. 130:507. PubMed
  93. Son YM, et al. 2020. Eur J Immunol. 50:1067. PubMed
  94. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  95. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  96. Peng V, et al. 2020. J Biol Chem. 295:14866. PubMed
  97. Mayer JU, et al. 2020. Front Immunol. 11:592325. PubMed
  98. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  99. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  100. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  101. Lee JH, et al. 2022. iScience. 25:104166. PubMed
  102. Schnoegl D, et al. 2022. Front Immunol. 13:909270. PubMed
  103. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  104. Calcagno DM, et al. 2020. Sci Immunol. 5: . PubMed
  105. Malinczak CA, et al. 2021. J Immunol. 206:1315. PubMed
  106. Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed
  107. Valet C, et al. 2022. J Clin Invest. 132: . PubMed
  108. Avalos A, et al. 2022. JCI Insight. 7: . PubMed
  109. Campisi L, et al. 2022. Nature. 606:945. PubMed
  110. Piñeros AR, et al. 2022. Cell Rep. 39:111011. PubMed
  111. Xu C, et al. 2022. iScience. 25:105123. PubMed
  112. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  113. Frede A, et al. 2022. Immunity. 55:2336. PubMed
  114. Milutinovic S, et al. 2022. Cancer Res Commun. 2:1641. PubMed
  115. Hailemichael Y, et al. 2022. Cancer Cell. 40:509. PubMed
  116. Shirai T, et al. 2022. Cancer Sci. 113:3710. PubMed
  117. Kang YA, et al. 2023. J Exp Med. 220:. PubMed
RRID
AB_312986 (BioLegend Cat. No. 103201)
AB_312987 (BioLegend Cat. No. 103202)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

B cells, T cell subset, NK cell subset

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Cell Type
B cells, NK cells, T cells
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID 5788 View all products for this Gene ID
UniProt
View information about CD45R on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 08.15.2022

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account